The following discussion should be read in conjunction with the financial statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q.





Our Business


Jubilant Flame International, Ltd., (the "Company", "the "Registrant", "we", "us" or "our") was formed on September 29, 2009 under the name Liberty Vision, Inc. The Company provided web development and marketing services for clients. On December 5, 2012, the Company disposed of its subsidiary corporation to a shareholder for a nominal sum, as well as other management operations. On December 16, 2012, the Company changed its name to Jiu Feng Investment Hong Kong, Inc. On January 27, 2013, the Company announced the change of its ticker symbol from "LBYV" to "JFIL." On July 24, 2013, the Company changed its business sector to the medical sector. On August 18, 2015 the Company changed its name to Jubilant Flame International, Ltd.

From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products - in the United States market. In the beginning of 2020, the Company ceased the marketing and selling of cosmetic products in the United States.

From the third quarter of the year ended February 29, 2020, the company began providing technical support services for development of new nutrition food products to sell to customers in USA.






          3

  Table of Contents




 Results of Operations



 Revenue


We recognized no sales revenue in the three months ended May 31, 2022 compared to zero sales revenue in the three months ended May 31, 2021.





Operating Expenses


For the three months ended May 31, 2022 compared to the three months ended May 31, 2021

The major components of our operating expenses for the three months ended May 31, 2022 and 2021 are outlined in the table below:





                                  Three Months Ended       Three Months Ended
                                        May 31                   May 31
                                         2022                     2021

Officer stock compensation       $                  -     $              4,500
Professional fee                 $             14,413     $             14,272
OTC service expense and others   $              3,500     $              2,756
Total operating expenses         $             17,913     $             21,528



The $3,615 decrease in our operating costs for the three months ended May 31, 2022 compared to three months ended May 31, 2021, was mainly due to a decrease of $ 4,500 decrease in officer compensation fee.





Other Expenses


No other expenses incurred during the three-month periods ended May 31, 2022 and 2021.





Net Loss



For the three months ended May 31, 2022, we recognized a net loss of $17,913 compared to the net loss of $21,528 for the corresponding period in 2021.

Liquidity and Capital Resources





Working Capital



                             May 31,        February 28,
                               2022             2022
Current Assets             $     10,582     $      14,082
Current Liabilities        $  1,196,498     $   1,182,085
Working Capital Deficit    $ (1,185,916 )   $  (1,168,003 )





          4

  Table of Contents



As of May 31, 2022, the Company had current assets of $10,582, primarily comprising of cash of $3,582, prepaid expenses of $7,000 and current liabilities of $1,196,498, resulting in a working capital deficit of $1,185,916. The Company had limited profitable operation activities and has an accumulated deficit of $3,674,947 as at May 31, 2022. This raises substantial doubt about the Company's ability to continue as a going concern.

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

Based on the Company's current operating plan and global coronavirus pandemic impact , the Company does not have sufficient cash and cash equivalents to fund its operations for at least the next twelve months. The Company will need to obtain additional financing to operate our business. The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the nutrition product technology support sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.

Cash Flows from Operating Activities

Our net cash used in operating activities decreased by $6,615 in the three months ended May 31, 2022 compared to the net cash used in operating activities in the three months ended May 31, 2021. The decrease in net cash used in operating activities was primarily the result of a $7,000 increase in accrued professional fee.

Cash Flows from Investing Activities

We did not generate or use any cash from investing activities during the three months ended May 31, 2022 or 2021.

Cash Flows from Financing Activities

Our cash provided by financing activities decreased from $12,771 for the three months ended May 31, 2021 to $5,913 for the three months ended May 31, 2022. In both periods, cash was provided by the way of loans from related parties.





Future Financings


We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock, through an offering of debt securities, or through borrowings from financial institutions or related parties. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or through a loan from our directors to meet our obligations over the next twelve months.

Recent Accounting Pronouncements

In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for entities for the fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 on a prospective basis, with early adoption permitted. The company adopted the new standard effective March 1, 2021 and do not expect the adoption of this guidance to have a material impact on our consolidated financial statements.

In January 2020, the FASB issued Accounting Standards Update No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (ASU 2020-01), which clarifies the interaction of the accounting for equity securities under Topic 321, the accounting for equity method investments in Topic 323, and the accounting for certain forward contracts and purchased options in Topic 815. This guidance will be effective for entities for the fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 on a prospective basis, with early adoption permitted. The company adopted the new standard effective March 1, 2021 and doesn't have any equity security investment now.






          5

  Table of Contents




Off Balance Sheet Arrangements

As of May 31, 2022, we did not have any off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

© Edgar Online, source Glimpses